The Centers for Disease Control and Prevention said Friday morning that a new round of testing at the University of Nebraska Medical Center in Omaha turned up no confirmed hantavirus cases in the United States, a significant marker in the federal response to a global outbreak tied to the Antarctic cruise ship MV Hondius that has killed three people and sickened 10 worldwide.
The agency is still watching at least 41 people across 16 states who may have been exposed to the virus. Roughly half are isolating at home. The rest are being monitored at hospitals in Omaha, Atlanta, and Kansas City. But as of Friday, not one has tested positive on American soil.
That is the kind of outcome that careful, proportionate public-health work is supposed to produce, and it stands in sharp contrast to the panic-first instincts that defined the early COVID era. Federal officials deserve credit for saying so plainly.
Dr. Stephen Kornfeld, a physician from Oregon, was the only American passenger who tested positive aboard the Hondius before disembarking and returning to the country. A second test taken on the ship came back negative. NBC News reported that Kornfeld has remained asymptomatic since his return Monday and was moved from a biocontainment unit into a quarantine unit at the Nebraska medical center, joining 15 other U.S. passengers from the voyage.
Two additional passengers are being treated at Emory University Hospital in Atlanta. Kornfeld's negative result brought the global case count to 10, with three deaths among those. World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus said Friday that eight of the 10 cases have been confirmed by laboratory tests, while two remain suspected.
No new cases have been reported anywhere since May 2, nearly two weeks of silence on a virus that grabbed international headlines.
A State Department plane transported 17 Americans from the outbreak-linked cruise ship to Omaha. HHS said one passenger with mild symptoms would be treated separately, while another tested mildly positive for the Andes strain. Two others traveled in biocontainment units as a precaution, Just The News reported.
Acting CDC Director Jay Bhattacharya made a point of tamping down comparisons to the pandemic that reshaped American life for years.
"The key message I want to send to your audience is that this is not COVID. This is not going to... lead to the kind of outbreak."
That distinction matters. COVID spread through respiratory droplets with devastating efficiency. Hantavirus, specifically the Andes strain, the only known hantavirus capable of person-to-person transmission, usually requires prolonged, close contact. It is a different animal entirely.
The federal government's approach to health policy in this administration has leaned toward measured action rather than sweeping mandates, and the hantavirus response fits that pattern. Quarantine protocols are in place. Monitoring is active. But nobody shut down an airport or locked down a city.
Dr. Marc Siegel offered a blunt assessment of the gap between the two viruses. Fox News reported his view that hantavirus is mainly secretion-borne rather than airborne and is very difficult to transmit.
"There's no comparison between these two viruses, other than that the single-stranded RNA viruses are both carried by animals. It's not airborne... in terms of respiratory droplets hanging in the air. It's very difficult to transmit."
Siegel also noted that hantavirus has shown little genetic change over time, a fact that undercuts the fear that it might mutate into something more dangerous. The cruise ship outbreak appears tied to close-quarter exposure, not evidence of a broader human-to-human threat.
Americans who lived through years of shifting guidance, school closures, and economic disruption have earned the right to be skeptical when a new virus makes headlines. This time, the facts support calm. The outbreak is contained. The monitoring is working. The experts are speaking clearly instead of hedging for political cover.
North of the border, Canadian health officials said they are monitoring 36 people, including four cruise ship passengers, in isolation. So far, none are showing symptoms. The parallel monitoring effort suggests the international response has been coordinated and proportionate.
Meanwhile, 27 people remain aboard the Hondius as it sails back to the Netherlands to complete its journey. WHO's Tedros said the ship was expected to arrive Monday. The global health risk, in the organization's assessment, remains low.
CDC officials are encouraging the passengers quarantined in U.S. hospitals to stay put through the virus's full 42-day incubation period. That is a long stretch. But the reasoning is straightforward: patients could still test positive later despite earlier negative results. Caution now beats regret later.
CDC incident manager David Fitter framed the strategy in practical terms, as the Washington Examiner reported.
"Our approach is based on risk and evidence. We are working closely with passengers and public health partners to ensure monitoring and rapid access to care if symptoms develop."
Bhattacharya added that the United States "has systems in place to make sure that if something happens, that we respond appropriately." The Nebraska medical center's biocontainment capabilities have drawn praise throughout the response, a reminder that federal institutions work best when they stick to their core mission and resist the urge to grandstand.
Several questions hang over the situation. The CDC has not publicly identified which 16 states are involved in monitoring. The specific testing methods used in the latest round at the Nebraska facility have not been disclosed. And the origin point of the global outbreak, how the virus moved from rodent populations to cruise ship passengers in the first place, remains unclear.
These gaps are worth tracking. But they do not change the headline: zero confirmed cases in the United States, a contained monitoring operation, and a federal response that has so far avoided the overreach and confusion that marked the early days of COVID.
Public figures across Washington continue to face scrutiny on health-related matters, from questions about lawmakers' fitness to the long-term consequences of toxic exposure that public servants have endured. The hantavirus episode is a different kind of test, one the government appears to be passing.
Americans were promised after COVID that the next time would be different. So far, on hantavirus, it has been. The lesson is simple: respond to the threat in front of you, not the one cable news wants to sell.
